News

Archive / 2018

19 November 2018

Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech

26 October 2018

Immunocore CEO Andrew Hotchkiss appointed to the Board of the BIA

5 September 2018

Immunocore strengthens IP position in the field of TCR-based therapeutics

20 August 2018

Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours

16 July 2018

Immunocore Announces Management Change

4 June 2018

Immunocore Presents New IMCgp100-102 Data that Show Durable Response and Robust Overall Survival Rate in Patients with Metastatic Uveal Melanoma

22 May 2018

Immunocore to Present New Data from IMCgp100-102 Trial in Metastatic Uveal Melanoma at 2018 ASCO Annual Meeting

21 May 2018

Immunocore wins Large Business of the Year at the 2018 Vale4Business Awards

8 February 2018

Immunocore Announces Leadership Change

4 January 2018

Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors

News archive